CPHI Milan
October 6-8, 2026
Milan, Italy
https://www.cphi.com/europe/en/exhibit/book-your-stand-milan.html
AMW GmbH
Innovative medicines,
flexible platform
Our biodegradable drug delivery systems for controlled drug release can help support treatment adherence and enable cost-effective therapies. We currently have three products on the market: implants, which are distributed in numerous markets through local and global pharmaceutical partners. With state-of-the-art manufacturing facilities in Germany, we cover the entire pharmaceutical value chain. Our employees, with their individual ideas and skills, are crucial to our success.
Our products
Our biodegradable drug delivery systems for controlled drug release can help support treatment adherence and enable cost-effective therapies. We currently have three products on the market: implants, which are distributed in numerous markets through local and global pharmaceutical partners.
Partnering
From early feasibility assessment and development to scale-up, manufacturing and regulatory approval: our CDMO+ and co-development solutions provide a clearly structured B2B offering with defined entry points.
Preclinical development / feasibility assessment
Contract development
Process transfer / scale-up
GMP manufacturing
Regulatory affairs & market access
Hot Melt Extrusion
Licensing & distribution
We are a trusted partner to leading pharmaceutical companies and offer full licensing and support packages for products manufactured at our own facilities. As an experienced partner for research and development projects, we grant licensing and distribution rights worldwide for the commercialization of our products.
